KYNB as of Nov 1 · 14:00 ET
KYNBNasdaqPharmaceutical Preparations

Kyntra Bio, Inc. · Brief

Next report

8 days

Nov 9 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26—▲+0.14%—
quarterimplied−5%0+5%realized×
Q2 FY26—▲+0.14%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

11disclosed supplier and customer ties in SEC filingsSEC filings
6managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

Bear2

8 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
−0.95%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

KYNB report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.